580 related articles for article (PubMed ID: 27267134)
1. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.
Siegfried EC; Jaworski JC; Kaiser JD; Hebert AA
BMC Pediatr; 2016 Jun; 16():75. PubMed ID: 27267134
[TBL] [Abstract][Full Text] [Related]
2. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
3. Safety of topical medications in the management of paediatric atopic dermatitis: An updated systematic review.
Zhao S; Hwang A; Miller C; Lio P
Br J Clin Pharmacol; 2023 Jul; 89(7):2039-2065. PubMed ID: 37075252
[TBL] [Abstract][Full Text] [Related]
4. Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas.
Draelos ZD
Curr Med Res Opin; 2008 Apr; 24(4):985-94. PubMed ID: 18284804
[TBL] [Abstract][Full Text] [Related]
5. Topical calcineurin inhibitors for atopic dermatitis: review and treatment recommendations.
Carr WW
Paediatr Drugs; 2013 Aug; 15(4):303-10. PubMed ID: 23549982
[TBL] [Abstract][Full Text] [Related]
6. A Comparison of Topical Corticosteroids and Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis.
Pena J; Zameza PA; Pixley JN; Remitz A; Feldman SR
J Allergy Clin Immunol Pract; 2023 May; 11(5):1347-1359. PubMed ID: 36997119
[TBL] [Abstract][Full Text] [Related]
7. Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis.
El-Batawy MM; Bosseila MA; Mashaly HM; Hafez VS
J Dermatol Sci; 2009 May; 54(2):76-87. PubMed ID: 19303745
[TBL] [Abstract][Full Text] [Related]
8. Systematic review on the efficacy, safety, and cost-effectiveness of topical calcineurin inhibitors in atopic dermatitis.
Chia BK; Tey HL
Dermatitis; 2015; 26(3):122-32. PubMed ID: 25984688
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus ointment for the treatment of adult and pediatric atopic dermatitis: Review on safety and benefits.
Ohtsuki M; Morimoto H; Nakagawa H
J Dermatol; 2018 Aug; 45(8):936-942. PubMed ID: 29927498
[TBL] [Abstract][Full Text] [Related]
10. Topical calcineurin inhibitors in the treatment of oral lichen planus: a systematic review and meta-analysis.
Sun SL; Liu JJ; Zhong B; Wang JK; Jin X; Xu H; Yin FY; Liu TN; Chen QM; Zeng X
Br J Dermatol; 2019 Dec; 181(6):1166-1176. PubMed ID: 30903622
[TBL] [Abstract][Full Text] [Related]
11. Contemporary Role of Topical Calcineurin Inhibitors: A Pediatric Dermatology Perspective.
Fiorillo L; Marcoux D; Ramien M
J Cutan Med Surg; 2019; 23(4_suppl):11S-18S. PubMed ID: 31476940
[TBL] [Abstract][Full Text] [Related]
12. Topical treatment utilization for patients with atopic dermatitis in the United States, and budget impact analysis of crisaborole ointment, 2.
Clark R; Bozkaya D; Levenberg M; Faulkner S; Smith TW; Gerber RA
J Med Econ; 2018 Aug; 21(8):770-777. PubMed ID: 29706103
[TBL] [Abstract][Full Text] [Related]
13. The role of topical calcineurin inhibitors in atopic dermatitis.
Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
Breuer K; Werfel T; Kapp A
Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
[TBL] [Abstract][Full Text] [Related]
15. Stratification of atopic dermatitis patients by patterns of response to proactive therapy with topical tacrolimus: low serum IgE levels and inadequately controlled disease activity at the start of treatment predict its failure.
Kasai H; Kawasaki H; Fukushima-Nomura A; Yasuda-Sekiguchi F; Amagai M; Ebihara T; Tanese K
Ann Med; 2021 Dec; 53(1):2205-2214. PubMed ID: 34797182
[TBL] [Abstract][Full Text] [Related]
16. Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence.
Kalavala M; Dohil MA
Am J Clin Dermatol; 2011 Feb; 12(1):15-24. PubMed ID: 21067248
[TBL] [Abstract][Full Text] [Related]
17. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
Hebert AA
Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
[TBL] [Abstract][Full Text] [Related]
18. Evidence Review of Topical Calcineurin Inhibitors for the Treatment of Adult Atopic Dermatitis.
Hong CH; Gooderham M; Bissonnette R
J Cutan Med Surg; 2019; 23(4_suppl):5S-10S. PubMed ID: 31476937
[TBL] [Abstract][Full Text] [Related]
19. Unmet medical needs in the treatment of atopic dermatitis in infants: An Expert consensus on safety and efficacy of pimecrolimus.
Luger T; Augustin M; Lambert J; Paul C; Pincelli C; Torrelo A; Vestergaard C; Wahn U; Werfel T
Pediatr Allergy Immunol; 2021 Apr; 32(3):414-424. PubMed ID: 33251600
[TBL] [Abstract][Full Text] [Related]
20. Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis.
Legendre L; Barnetche T; Mazereeuw-Hautier J; Meyer N; Murrell D; Paul C
J Am Acad Dermatol; 2015 Jun; 72(6):992-1002. PubMed ID: 25840730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]